IN PICTURES: Two decades of HIV in South Africa
We reflect in pictures South Africa’s journey in the struggle against HIV since 2000.
COVID-19: Local researchers welcome Sputnik V vaccine findings
Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.
In-depth: Women living with HIV, still waiting on redress after ‘forced sterilisations’
Almost nine months since the Commission on Gender Equality (CGE) released a damning report with dozens of women living with HIV’s testimonies about forced sterilisations allegedly performed on them in public health facilities, the Department of Health has now moved to implement the Commission’s recommendations. Nomfundo Xolo reports.
Interactive table: See how SA’s provinces compare on the 90-90-90 targets
New estimates of HIV in South Africa’s provinces were made public last week. This interactive table shows how South Africa’s nine provinces compare on the UNAIDS 90-90-90 targets.
TB treatment time cut by a third
A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.
WHO estimates 20% more TB cases in SA than previously thought
Around 20% more people are falling ill with tuberculosis (TB) in South Africa, than previously thought. This emerged from new estimates contained in the 2020 WHO World TB Report launched today.
COVID-19: The danger of criminalisation
To single out a disease through specific laws or existing prosecution mechanisms places an unreasonable burden on the criminal justice system to address people’s behaviour. Our experience with HIV points to a better approach, argues Mbalenhle Baduza.
